Prion strains

Prions in Humans and Animals

Volumn , Issue , 2006, Pages 166-186

  Groschup, Martin H ^a   Gretzschel, Anja ^a   Kuczius, Thorsten ^b  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881752819     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1515/9783110200171     Document Type: Chapter

References (88)

1. Adams DH. Relation between Carp (multiple-sclerosis associated) agent and multiple sclerosis. Lancet 1976; 1:444-446.
2. Pattison IH and Millson GC. Scrapie produced experimentally in goats with special reference to the clinical syndrome. J Comp Pathol 1961: 71:101-108.
3. Fraser H and Dickinson AG. The sequential development of the brain lesions of scrapie in three strains of mice. J Comp Pathol 1968; 78:301-311.
4. Bruce ME. Strain typing studies of scrapie and BSE. In: Baker HF, Ridley RM, editors. Methods in molecular medicine: Prion diseases. Humana Press, Totowa, NJ, 1996: 223-238.
5. Bruce ME and Dickinson AG. Biological stability of different classes of scrapie agent. In: Prusiner SB, Hadlow WJ, editors. Slow transmissible diseases of the nervous system. Academic Press, New York, Vol 2, 1979: 71-86.
6. Mori S, Hamada C, Kumanishi T, et al. A Creutzfeldt-Jakob disease agent (Echigo-1 strain) recovered from brain tissue showing the 'panencephalopathic type' disease. Neurology 1989; 39:1337-1342.
7. Bruce ME, McConnell I, Fraser H, et al. The disease characteristics of different strains of scrapie in Sine congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 1991; 72:595-603.
8. Dickinson AG and Meikle VM. Host-genotype and agent effects in scrapie incubation: change in allelic interaction with different strains of agent. Mol Gen Genet 1971; 112:73-79.
9. Kimberlin RH, Cole S, Walker C. Transmissible mink encephalopathy (TME) in Chinese hamsters: identification of two strains of TME and comparisons with scrapie. Neuropathol Appl Neurobiol 1986; 12:197-206.
10. Kimberlin RH and Walker C. Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J Gen Virol 1978; 39:487-496.
11. DeArmond SJ, Mobley WC, DeMott DL, et al. Changes in the localization of brain prion proteins during scrapie infection (published erratum appears in Neurology 1987 Nov; 37(11):1770). Neurology 1987; 37:1271-1280.
12. Anonym. Obese protein slims mice (news). Science 1995; 269:475-476, 540, 543, 546.
13. Kascsak RJ, Rubenstein R, Merz PA, et al. Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol 1986; 59:676-683.
14. Carp RI, Callahan SM, Sersen EA, et al. Preclinical changes in weight of scrapie-infected mice as a function of scrapie agent-mouse strain combination. Intervirology 1984; 21:61-69.
15. Kim YS, Carp RI, Callahan SM, et al. Scrapie-induced obesity in mice. J Infect Dis 1987: 156:402-405.
16. Kaneko K, Wille H, Mehlhom I, et al. Molecular properties of complexes formed between the prion protein and synthetic peptides. J Mol Biol 1997; 270(4):574-586.
17. Outram GW Changes in drinking and feeding habits of mice with experimental scrapie. J Comp Pathol 1972; 82:415-427.
18. Carp RI, Kim YS, Callahan SM. Scrapie-in-duced alterations in glucose tolerance in mice. J Gen Virol 1989; 70:827-835.
19. Bessen RA and Marsh RF Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 1992; 66:2096-2101.
20. Bessen RA and Marsh RF. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 1994; 68:7859-7868.
21. Bessen RA and Marsh RF. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 1992; 73:329-334.
22. Pattison IH. The relative susceptibility of sheep. goats and mice to two types of the goat scrapie agent. Res Vet Sci 1966; 7:207-212.
23. Chandler RL. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1961; 1:1378-1379.
24. Bruce ME, and Fraser H. Scrapie strain variation and its implications. Curr Top Microbiol Immunol 1991; 172:125-138.
25. Bruce ME, McConnell I, Fraser H, Dickinson AG. The disease characteristics of different strains of scrapie in Sine congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 1991; 72: 595-603.
26. Fraser HM, Bruce ME, McConnell I. Murine scrapie strains, BSE models and genetics. In: Bradley R, Savey M, Marchant B, editors. Subacute Spongiform Encephalopathies. Commission of European Communities. Kluwer Academic, Netherlands, 1991:131-136.
27. Bruce ME, Boyle A, Cousens S, et al. Strain characterization of natural sheep scrapie and comparison with BSE. J Gen Virol 2002; 83(Pt 3):695-704.
28. Dickinson AG and Fraser H. Scrapie pathogenesis in inbred mice: an assessment of host control and response involving many strains of agent. In: Ter Meulen V, Katz M, editors. Slow virus infections of the central nervous system. Springer, Berlin, 1977:3-14.
29. Dickinson AG, Meikle VM, Fraser H. Identification of a gene which controls the incubation period of some strains of scrapie in mice. J Comp Pathol 1968; 78:293-299.
30. Carlson GA, Kingsbury DT, Goodman PA, et al. Linkage of prion protein and scrapie incubation time genes. Cell 1986; 46:503-511.
31. Hunter N, Hope J, McConnell I, et al. Linkage of the scrapie-associated fibril protein (PrP) gene and Sine using congenic mice and restriction fragment length polymorphism analysis. J Gen Virol 1987; 68:2711-2716.
32. European Community 1990. Council Directive 90/667/EEC of 27 November 1990 laying down the veterinary rules for the disposal and processing of animal waste, for its placing on the market and for the prevention of pathogens in feedstuffs of animal or fish origin and amending Directive 90/425/EEC.
33. Hunter N. Genotyping and susceptibility of sheep to scrapie. In: Baker HF, Ridley RM, editors. Methods in molecular medicine: Prion diseases. Humana Press, Totowa, NJ, 1996:211-221.
34. Sander P, Hamann H, Pfeiffer I, et al. Analysis of the sequence variability of the bovine prion protein gene (PRNP) in German cattle breeds. Neurogenetics 2005; 5:19-25.
35. Lloyd SE, Onwuazor ON, Beck JA, et al. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci U S A 2001; 98:6279-6283.
36. Carp RI, Meeker H, Sersen E. Scrapie strains retain their distinctive characteristics following passages of homogenates from different brain regions and spleen. J Gen Virol 1997; 78(Part l):283-290.
37. Bruce ME, Dickinson AG, Fraser H. Cerebral amyloidosis in scrapie in the mouse: effect of agent strain and mouse genotype. Neuropathol Appl Neurobiol 1976; 2:471-478.
38. Scott JR and Fraser H. Degenerative hippocam-pal pathology in mice infected with scrapie. Acta Neuropathol (Berl) 1984; 65:62-68.
39. Foster JD, Fraser H, Bruce ME. Retinopathy in mice with experimental scrapie. Neuropathol Appl Neurobiol 1986; 12:185-196.
40. Fraser H and Dickinson AG. Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J Comp Pathol 1973; 83:29-40.
41. Bruce ME, Chree A, McConnell I, et al. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond B 1994: 343:405-411.
42. Brown DA, Bruce ME, Fraser JR, et al. Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice. Neuropathol Appl Neurobiol 2003; 29:262-272.
43. Kimberlin RH, Walker C, Millson GC et al. Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents. J Neurol Sci 1983: 59:355-369.
44. Taylor DM, Fraser H, McConnell I, et al. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol 1994; 139:313-326.
45. McKinley MP, Bolton DC, Prusiner SB. A pro-tease-resistant protein is a structural component of the scrapie prion. Cell 1983; 35:57-62.
46. Merz PA, Kascsak RJ, Rubenstein R, et al. Anti-sera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils. J Virol 1987; 61:42-49.
47. Prusiner SB. Molecular biology of prion diseases. Science 1991; 252:1515-1522.
48. Prusiner SB, Bolton DC, Groth DF, et al. Further purification and characterization of scrapie prions. Biochemistry 1982; 21:6942-6950.
49. Prusiner SB, McKinley MP, Bowman KA, et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 1983; 35:349-358.
50. Merz PA, Rohwer RG, Kascsak R, et al. Infection-specific particle from the unconventional slow virus diseases. Science 1984; 225:437-440.
51. Merz PA, Somerville RA, Wisniewski HM, et al. Abnormal fibrils from scrapie-infected brain. Acta Neuropathol 1981; 54:63-74.
52. Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982; 218:1309-1311.
53. Diringer H, Gelderblom H, Hilmert H, et al. Scrapie infectivity, fibrils and low molecular weight protein. Nature 1983; 306:476-478.
54. Adams JM. Persistent or slow viral infections and related diseases. West J Med 1975; 122:380-393.
55. Kascsak RJ, Rubenstein R, Merz PA, et al. Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents. J Gen Virol 1985; 66:1715-1722.
56. Lezmi S, Martin S, Simon S, et al. Comparative molecular analysis of the abnormal prion protein in field scrapie cases and experimental bovine spongiform encephalopathy in sheep by use of western blotting and immunohistochemical methods. J Gen Virol 2004; 78:3654-3662.
57. Hope J, Morton LJ, Farquhar CF, et al. The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO J 1986: 5:2591-2597.
58. Hope J, Multhaup G, Reekie LJ, et al. Molecular pathology of scrapie-associated fibril protein (PrP) in mouse brain affected by the ME7 strain of scrapie. Eur J Biochem 1988; 172:271-277.
59. Manuelidis L, Valley S, Manuelidis EE. Specific proteins associated with Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants. Proc Natl Acad Sci U S A 1985; 82:4263-4267.
60. Oesch B, Westaway D, Walchli M, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985; 40:735-746.
61. Rubenstein R, Merz PA, Kascsak RJ, et al. Detection of scrapie-associated fibrils (SAF) and SAF proteins from scrapie-affected sheep. J Infect Dis 1987; 156:36-42.
62. Hayashi HK, Yokoyama T, Takata M, et al. The N-terminal cleavage site of PrP(Sc) from BSE differs from that of PrP(Sc) from scrapie. Biochem Biophys Res Commun 2005; 328:1024-1027.
63. Nonno R, Esposito E, Vaccari G, et al. Molecular analysis of Italian sheep scrapie and comparison with cases of bovine spongiform encephalopathy (BSE) and experimental BSE in sheep. J Clin Microbiol 2003; 41:4127-4133.
64. Thuring CMA, Erkens JH, Jacobs JG, et al. Discrimination between scrapie and bovine spongiform encephalopathy in sheep by molecular size. immunoreactivity and glycoprofile of prion protein. J Clin Microbiol 2004; 42:972-980.
65. Collinge J, Sidle KC, Meads J, et al. Molecular analysis of prion strain variation and the aetiology of'new variant'CJD. Nature 1996; 383:685-690.
66. Kuczius T, Haist I, Groschup MH. Molecular analysis of BSE and scrapie strain variation. J Infect Dis 1998; 178:693-699.
67. Somerville RA, Chong A, Mulqueen OU, et al. Biochemical typing of scrapie strains. Nature 1997; 386:564.
68. Telling GC, Parchi P, DeArmond SJ, et al. Evidence for the conformation of the pathologic iso-form of the prion protein enciphering and propagating prion diversity. Science 1996; 274:2079-2082.
69. Hope J, Wood SC, Birkett CR, et al. Molecular analysis of ovine prion protein identifies similarities between BSE and an experimental isolate of natural scrapie, CH 1641. J Gen Virol 1999: 80:1-4.
70. Casalone C, Zanusso G, Acutis P, et al. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Adad Sci USA 2004; 101:3065-3070.
71. Biacabe AG, Laplanche JL, Ryder S, et al. Distinct molecular phenotypes in bovine prion diseases. EMBO Rep 2004; 5:110-115.
72. Lloyd SE, Linehan JM, Desbruslais M, et al. Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice. J Gen Virol 2004: 85:2471-2478.
73. Bartz JC, Bessen RA, McKenzie D, et al. Adaptation and selction of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J Gen Microbiol 2000; 74:5542-5547.
74. Bruce ME and Dickinson AG. Biological evidence that scrapie agent has an independent genome. J Gen Virol 1987; 68:79-89.
75. Foster JD and Dickinson AG. The unusual properties of CH1641, a sheep-passaged isolate of scrapie. Vet Rec 1988; 123:5-8.
76. Parchi R Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46(2):224-233.
77. Notari S, Capellari S, Giese A, et al. Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem 2004; 279(16):16797-16804.
78. Dickinson AG. Scrapie in sheep and goats. Front Biol 1976; 44:209-241.
79. Morgan KL, Nicholas K, Glover MJ, et al. A questionnaire survey of the prevalence of scrapie in sheep in Britain. Vet Rec 1990; 127:373-376.
80. Anonym. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 43-1977. N Engl J Med 1977; 297:930-937.
81. Buschmann A, Gretzschel A, Biacabe AG, et al. Atypical BSE cases in Germany - proof of trans-missibility and biochemical characterization. Vet Microbiol 2006; submitted.
82. O'Rourke KI, Spraker TR, Hamburg LK, et al. Polymorphisms in the prion precursor functional gene but not the pseudogene are associated with susceptebility to chronic wasting disease in white-tailed deer. J Gen Virol 2004; 85:1339-1346.
83. O'Rourke KI, Besser TE, Miller MW, et al. PrP genotypes of captive and free-ranging Rocky Mountain elk (Cervus elaphus nelsoni) with chronic wasting disease. J Gen Microbiol 1999; 80:2765-2779.
84. Salman MD. Chronic wasting disease in deer and elk: scientific facts and findings. J Vet Med Sci 2003; 65:761-768.
85. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that new variant CJD is caused by the BSE agent. Nature 1997: 389:498-501.
86. Williams ES and Young S. Spongiform encephalopathy of Rocky Mountain elk. J Wildl Dis 1982; 18:465-471.
87. Williams ES and Young S. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis 1980; 16:89-98.
88. Race RE, Raines A, Baron TG, et al. Comparison of abnormal prion protein glycoform patterns from transmissible spongiform encephalopathy agent-infected deer, elk, sheep and cattle. J Gen Virol 2002; 76:12365-12368.